远大医药集团有限公司（00512）于2026年2月3日发布截至2026年1月31日的股份变动月报表。公告显示，公司法定注册股本维持为100,000,000,000股，面值每股0.01港元，总额1,000,000,000港元。截至报告期末，已发行普通股总数为3,549,571,148股，与上月底一致，未见新增发行、购回或注销记录，库存股份亦无变动。
根据公告，公司已确认满足香港联合交易所有限公司关于最低公众持股量的要求。公司表示，本月所有证券发行业务均符合相关监管规定，并由董事会正式授权批准。该份月报由公司秘书傅天忠签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.